RT @drcaplan: Appealing long-term use data for interest. In 2013, Journal of Molecular Medicine,146 patients over 334 days.THC+CBD in Sativ…
106 followers
224 followers
RT @drcaplan: Appealing long-term use data for interest. In 2013, Journal of Molecular Medicine,146 patients over 334 days.THC+CBD in Sativ…
7,132 followers
Appealing long-term use data for interest. In 2013, Journal of Molecular Medicine,146 patients over 334 days.THC+CBD in Sativex had clinically relevant effect on spasticity in Multiple Sclerosis. #MedicalCannabis , #MedicalMarijuana , #MultipleSclerosis
1,940 followers
146 patients with MS took Sativex for an average of 334 days each and not one of them suffered from psychosis... http://t.co/EZOSJfZE